The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK

Autor: Meadows, H. J., Chapman, C. G., Duckworth, D. M., Kelsell, R. E., Murdock, P. R., Nasir, S., Rennie, G., Randall, A. D.
Zdroj: Brain Research; 2001, Vol. 892 Issue: 1 p94-101, 8p
Databáze: Supplemental Index